News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
DCIS linked to higher breast cancer mortality, despite treatment
By Marilynn Larkin NEW YORK (Reuters Health) - The risk of dying from breast cancer is about three times higher in women with carcinoma in situ (DCIS) than in the general population, even after
Ban on cornea donation from gay and bisexual men outdated, wastes eyes
By Linda Carroll (Reuters Health) - The current U.S. ban on cornea donation from men who have had sex with men in the prior five years may result in as many as 3,000 potential corneas being wasted
Arthroscopic partial meniscectomy tied to radiographic knee osteoarthritis
By Lisa Rapaport (Reuters Health) - Patients with a degenerative meniscus tear who get arthroscopic partial meniscectomy have similar five-year outcomes and increased risk of radiographic knee
U.S. vaccine program chief backs stricter rules for emergency use of COVID-19 shot
By Julie Steenhuysen CHICAGO (Reuters) - The scientific head of the U.S. government program designed to speed development of COVID-19 vaccines said on Thursday he supports stricter rules to grant
Cuomo says New York to review any COVID-19 vaccine authorized by federal govt
By Maria Caspani (Reuters) - New York Governor Andrew Cuomo on Thursday said the state will carry out its own review of coronavirus vaccines authorized or approved by the federal government due to
Motivational interviewing can reduce adolescent alcohol use
By Lisa Rapaport (Reuters Health) - Motivational interviewing can help reduce the frequency of adolescent alcohol use and how often they experience problems related to substance use, a meta-analysis
Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial
By Reuters Staff FRANKFURT (Reuters) - Pfizer's German development partner BioNTech on Thursday joined other leading COVID-19 vaccine developers in ruling out participation in British plans to test
Cases of nut anaphylaxis spike in children at Halloween and Easter
By Linda Carroll (Reuters Health) - The number of children showing up in emergency departments with anaphylaxis may spike during Halloween and Easter, a new study suggests. Canadian researchers found
UK's Integumen unveils prototype COVID-19 breath test
By Reuters Staff LONDON (Reuters) - Integumen, a British company that developed a system to detect the COVID-19 virus in waste water, said the same technology could be deployed in a personalised
Becton Dickinson reaches $60 million settlement over pelvic mesh devices
By Jonathan Stempel NEW YORK (Reuters) - Becton Dickinson and Co said on Thursday it has reached a $60 million settlement with the attorneys general of 48 U.S. states and Washington D.C., resolving
COVID-19 may damage monocytes in bone marrow
By Reuters Staff (Reuters) - Even the bone marrow may not be a safe harbor from the effects of SARS-CoV-2, according to a study that found previously unrecognized changes in the innate immune
Melanoma patients still at higher risk for new malignancy after successful systemic immunotherapy
By David Douglas NEW YORK (Reuters Health) - Patients successfully treated for metastatic melanoma with immune-checkpoint inhibitors remain at increased risk for developing new primary cutaneous
Peer-support programs can help parents of gender-diverse youth
By Carolyn Crist NEW YORK (Reuters Health) - Parents of transgender, gender-nonconforming or gender-diverse youth may seek support from other parents to gain a greater understanding of the resources
Rates of recurrent CHD events dropping in U.S.
By Anne Harding NEW YORK (Reuters Health) - Recurrent coronary heart disease (CHD) events declined for both men and women from 2008 to 2017, with a greater proportional decline for women, according to
Hispanic, Black, poor children more likely to test positive for SARS-CoV-2
By Will Boggs MD NEW YORK (Reuters Health) - Black and Hispanic children and those from lower socioeconomic groups are more likely than others to test positive for SARS-CoV-2, according to a new U.S.
Dapagliflozin again shows kidney, cardiovascular benefit beyond glucose control
By Reuters Staff (Reuters Health) - The diabetes drug dapagliflozin can prevent decline in kidney function among patients with chronic kidney disease, according to new results from the DAPA-CKD trial.
Glycans in SARS-CoV-2 spike protein play key role in binding to host cells
By Will Boggs MD NEW YORK (Reuters Health) - Glycans coating the spike protein of SARS-CoV-2 facilitate conformational changes needed to bind to ACE2 and infect host cells, researchers report. "Our
COVID-19 croup may be more severe than typical croup
By Megan Brooks NEW YORK (Reuters Health) - Clinicians from Virginia report what they believe are the first documented cases of croup as a manifestation of SARS-CoV-2 infection. The limited experience
High COVID-19 mortality seen in assisted-living facilities
By Reuters Staff (Reuters) - Data compiled from more than 4,600 assisted living facilities in seven U.S. states through the end of May showed a four-fold higher COVID-19 fatality rate than in the
CORRECTED-High-resolution CT no extra help in fracture risk screening in women
(Corrects first para of Sept. 15 story by adding missing text.) By Reuters Staff NEW YORK (Reuters Health) - High-resolution peripheral quantitative computed tomography (HR-pQCT) does not improve upon
AstraZeneca still waiting for FDA go-ahead to resume U.S. trial
By Ludwig Burger and Caroline Copley FRANKFURT (Reuters) - AstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine in
As COVID surges in Europe, officials warn of "twindemic" with flu
By Kate Kelland LONDON (Reuters) - A surge in COVID-19 cases in Europe risks becoming a deadly double epidemic of flu and coronavirus infections, EU health officials warned on Thursday as they urged
England Test and Trace reports tripling of COVID-19 cases since late August
By Reuters Staff LONDON (Reuters) - Three times as many people tested positive for COVID-19 in England in latest weekly figures compared to the end of August, NHS Test and Trace said on Thursday, with
COVID rising again in Sweden amid return to 'hugs and parties' -PM
By Reuters Staff STOCKHOLM (Reuters) - Some areas of Sweden are seeing a worrying resurgence of coronavirus infections because many people seem to have set aside months of caution in favour of full-on
Trump says may block stricter FDA guidelines for COVID-19 vaccine
By Jeff Mason WASHINGTON (Reuters) - U.S. President Donald Trump said on Wednesday he may or may not approve any new, more stringent FDA standards for an emergency authorization of a COVID-19 vaccine,
EXCLUSIVE-Top adviser steps aside from FDA COVID-19 vaccine reviews over potential conflict
By Dan Levine and Marisa Taylor (Reuters) - A physician who heads the influential U.S. Food and Drug Administration vaccine advisory committee recused herself from the panel's review of COVID-19
Parental touch soothes pain signals in babies' brains
By Kate Kelland LONDON (Reuters) - Newborn babies undergoing a painful heel prick blood test have a reduced response to the pain signals in their brains if they are held by a parent with skin-to-skin
Houston study: More contagious coronavirus strain now dominates
By Deena Beasley (Reuters) - The first study to analyze the structure of the novel coronavirus from two waves of infection in a major city found that a more contagious strain dominates recent samples,
REFILE-Medical treatment likely bests endovascular therapy for symptomatic intracranial artery stenosis
(Changes "ICAD" to "ICAS" in para 3 of Sept. 9 story.) By Marilynn Larkin NEW YORK (Reuters Health) - In patients with symptomatic intracranial atherosclerotic stenosis (ICAS), endovascular therapy (
REFILE-Life-prolonging cancer treatments should continue: ESMO
(Corrects spelling of Herceptin in para 3 of July 31 story.) By Reuters Staff (Reuters Health) - In most cases, cancer treatment that improves a patient's odds of survival should not be stopped or
OTC cognitive supplements may contain multiple unapproved drugs
By Lisa Rapaport (Reuters Health) - Over-the-counter supplements promoted as brain boosters may contain a variety of unapproved drugs in doses and combinations that could be harmful, a new study finds
Statins tied to lower risk of severe COVID-19, shorter recovery times
By Lisa Rapaport (Reuters Health) - Patients hospitalized with COVID-19 may have a lower risk of severe disease and faster recovery times if they were taking statins prior to admission, a new study
Low-dose zinc effective against acute childhood diarrhea
By Gene Emery (Reuters Health) - Doctors who use zinc to treat children for acute diarrhea can throttle back on the recommended dose and may, in the process, prevent the vomiting that can accompany
Ertugliflozin passes post-approval cardiovascular safety test
By Gene Emery (Reuters Health) - Oral ertugliflozin, approved in December 2017 as a therapy for type 2 diabetes, shows no signs of producing major cardiovascular problems and appears to reduce
Genetic testing may miss epivariants that contribute to disease
By Marilynn Larkin NEW YORK (Reuters Health) - Standard DNA-based genetic testing could miss epigenetic variants linked to disease, researchers say. "Often patients who appear to have a genetic
Supportive care suffices for most children with COVID-19, new guidance suggests
By Marilynn Larkin NEW YORK (Reuters Health) - Supportive care is sufficient to treat the majority of children with COVID-19, since most will be only mildly ill, an expert pediatric infectious
UPDATE 1-J&J kicks off study of single-shot COVID-19 vaccine in 60,000 volunteers
(Recasts first paragraph, adds details on second, two-dose study) By Julie Steenhuysen CHICAGO (Reuters) - Johnson & Johnson on Wednesday began a 60,000-person trial of an experimental single-shot
It may take several tries to find right COVID-19 vaccine, PAHO director says
By Julia Symmes Cobb BOGOTA (Reuters) - It may take several tries to find the right vaccine for COVID-19, the Pan American Health Organization's (PAHO) director Carissa Etienne said on Wednesday, as
FOCUS-Positive about flying? Airlines look to COVID tests that give results in minutes
By John Miller and Emilio Parodi ZURICH/MILAN (Reuters) - European airlines are pinning hopes on pre-flight COVID-19 tests that deliver results as fast as pregnancy tests to help restore passengers'
Most Americans to be vaccinated for COVID-19 by July, CDC chief expects
By Reuters Staff (Reuters) - A top U.S. health official told a U.S. Senate committee on Wednesday that he expects COVID-19 vaccinations to take place over many months and that most Americans could be
UPDATE 1-UK to host 'human challenge' trials for COVID-19 vaccines - FT
(Adds statements from Imperial College London and 1Day Sooner) By Reuters Staff (Reuters) - Britain will host clinical trials where volunteers are deliberately infected with the new coronavirus to
J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers
By Julie Steenhuysen CHICAGO (Reuters) - Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify distribution of
Madrid pleads for more doctors, police as coronavirus cases surge
By Reuters Staff MADRID (Reuters) - Authorities in Spain's Madrid region on Wednesday requested urgent help to hire hundreds of foreign doctors and reinforce police, as they mulled widening a partial
Novartis faces delay after FDA asks for another Zolgensma study
By John Miller ZURICH (Reuters) - Novartis's bid to expand its $2.1 million-per-patient gene therapy Zolgensma to more spinal muscular atrophy patients faces a possible delay after U.S. regulators
German doctor held on suspicion of drugging, raping patients -media report
By Reuters Staff BIELEFELD, Germany (Reuters) - A hospital doctor in Germany has been arrested on suspicion of sedating women who had come to him for an MRT scan, and then filming himself raping them,
Roche Alzheimer's drug fails, joining long list of trial flops
By Reuters Staff ZURICH (Reuters) - An experimental Alzheimer's drug from Roche and AC Immune failed to slow cognitive and functional decline in a trial, the Swiss companies said on Wednesday, in a
Treatment times of acute STEMI have increased with COVID-19 pandemic
By Will Boggs MD NEW YORK (Reuters Health) - Times to treatment and mortality of acute ST-segment elevation myocardial infarction (STEMI) have increased since the onset of the COVID-19 pandemic,
Proton-pump inhibitors may reduce benefits of atezolizumab in urothelial carcinoma
By Will Boggs MD NEW YORK (Reuters Health) - The use of proton-pump inhibitors (PPIs) is associated with worse overall survival in patients with urothelial carcinoma treated with the immune-checkpoint
Bicuspid-aortic-valve repair shows long-term efficacy
By Reuters Staff NEW YORK (Reuters Health) - A large proportion of bicuspid aortic valve (BAV) repairs using a modified anatomy-based technique remain stable and lead to excellent long-term survival,
Depression and anxiety are biochemically different
By Megan Brooks NEW YORK (Reuters Health) - Depression and anxiety share similar symptoms and risk factors, often co-occur and are therefore assumed to be closely related. But for the first time a
U.S. FDA to tighten coronavirus vaccine authorization standards ahead of election -paper
By Reuters Staff (Reuters) - The U.S. Food and Drug Administration is expected to soon announce new, more stringent standards for an emergency authorization of a COVID-19 vaccine, lowering the chances
UK to host 'human challenge' trials for COVID-19 vaccines - FT
By Reuters Staff (Reuters) - Britain will host clinical trials where volunteers are deliberately infected with the new coronavirus to test the effectiveness of vaccine candidates, the Financial Times
Violence mounts against Iraqi doctors as COVID cases spike
By Amina Ismail NAJAF, Iraq (Reuters) - Iraqi doctor Tariq Al-Sheibani remembers little else beyond cowering on the ground as a dozen relatives of a patient, who had just died of COVID-19, beat him
Cytotoxic T cell therapy might be possible in COVID-19
By Reuters Staff (Reuters) - Cytotoxic T cell therapy may be feasible in patients with COVID-19 despite a potential hurdle, researchers say. The approach involves treating critically ill COVID-19
COVID-19 reinfections occur, but remain rare
By Reuters Staff (Reuters) - Another case of reinfection after recovery from COVID-19 has been reported, this time in a healthy young military healthcare provider at a U.S. Department of Defense
Most SARS-CoV-2 infections are symptomatic, study suggests
By Linda Carroll (Reuters Health) - Among those infected with SARS-CoV-2, only a minority will be asymptomatic, Swiss researchers say. In a systematic review that included nearly 80 studies of people
Non-physicians may optimize heart failure drugs remotely
By Marilynn Larkin NEW YORK (Reuters Health) - Remote optimization of drugs for heart failure patients with reduced ejection fraction (HFrEF) could support implementation of guideline-directed medical
Weekly insulin icodec is as effective as daily glargine in type 2 diabetics
By Reuters Staff (Reuters Health) - A 26-week phase 2 trial of insulin icodec has concluded that the experimental weekly therapy works as well and is just as safe for patients with type 2 diabetes as
Weekly insulin icodec is as effective as daily glargine in type 2 diabetics
By Reuters Staff (Reuters Health) - A 26-week phase 2 trial of insulin icodec has concluded that the experimental weekly therapy works as well and is just as safe for patients with type 2 diabetes as
Night-to-night variability in respiratory events among apnea patients
By Lisa Rapaport (Reuters Health) - Individual patients with obstructive sleep apnea may experience considerable night-to-night variability in respiratory events, a recent meta-analysis suggests.
U.S. health agency sets Oct. 16 deadline for states to submit vaccine plans
By Julie Steenhuysen and Manojna Maddipatla (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday set an Oct. 16 deadline for states to submit plans for distributing COVID-
Low-dose glucocorticoids for rheumatoid arthritis may still carry some risk of serious infections
By Will Boggs MD NEW YORK (Reuters Health) - Even low-dose glucocorticoid treatment is associated with an increased risk of serious infection in patients with rheumatoid arthritis (RA), according to a
Severe COVID-19 less common in patients with GI symptoms
By Reuters Staff (Reuters) - People with gastrointestinal symptoms related to the new coronavirus, like diarrhea, nausea and vomiting, may be significantly less likely to develop severe COVID-19 and
Antibody-binding might not neutralize SARS-CoV-2
By Reuters Staff (Reuters) - The spike protein on the surface of the new coronavirus helps it invade cells, and some antibodies being tested as treatments work by attaching to the spike and disabling
Tool sorts hospitalized COVID-19 patients by risk
By Reuters Staff (Reuters) - A simple 21-point scoring system helps assign hospitalized COVID-19 patients to different risk groups, UK researchers reported in The BMJ. The score takes 8 factors into
Previous COVID-19 not linked with childbirth complications
By Reuters Staff (Reuters) - For otherwise healthy women giving birth, previous exposure to the novel coronavirus appears not to impact labor and delivery, a new study suggests. From early April to
Shortage of naive T cells raises COVID-19 risk in elderly
By Reuters Staff (Reuters) - A lower supply of a certain type of immune cell in older people that is critical to fighting foreign invaders may help explain their vulnerability to severe COVID-19,
Povidone-iodine nasal spray may help limit coronavirus spread
By Reuters Staff (Reuters) - An antiseptic nasal spray containing povidone-iodine may help curb transmission of the new coronavirus, preliminary research suggests. In test tube experiments,
Not all COVID-19 antibody tests are equal
By Reuters Staff (Reuters) - Some COVID-19 antibody tests are much more reliable than others. But even with the best ones, reliability varies among patient subgroups, a new study suggests. In a study
COVID-19 has disrupted cancer care, particularly among minority groups
By Megan Brooks NEW YORK (Reuters Health) - The COVID-19 pandemic has led to significant disruptions in routine cancer care, especially among racial and ethnic minority groups, according to the COVID-
Corneal-cell injection ongoing success in bullous keratopathy
By Reuters Staff NEW YORK (Reuters Health) - Most patients who underwent injection of cultured human corneal endothelial cells (hCECs) more than five years ago because of corneal endothelial failure
Gestational age at birth linked to brain volume at age 10
By Anne Harding NEW YORK (Reuters Health) - Gestational age at birth (GAB) is associated with brain morphometry at 10 years of age, even for children delivered at term, new findings show. "The longer
Transthoracic echocardiography feasible during prone-position ventilation
By Will Boggs MD NEW YORK (Reuters Health) - A few modifications in technique make it possible to perform transthoracic echocardiography (TTE) during prone position ventilation, researchers in Mexico
Cough syrups' sweetness, viscosity drive their effectiveness
By Anne Harding NEW YORK (Reuters Health) - Over-the-counter cough medicines help ease cough due to the common cold because they're sweet and viscous, not because they contain active ingredients like
Longer treatment delays, worse outcomes for in-hospital ischemic stroke
By Will Boggs MD NEW YORK (Reuters Health) - Times to reperfusion are longer and functional outcomes worse for patients with in-hospital ischemic stroke, compared with those having out-of-hospital
Macron says France must not lock up elderly in nursing homes as COVID-19 cases rise
By Reuters Staff PARIS (Reuters) - France must do everything possible to avoid locking up elderly people in nursing homes to protect them from a resurgence in coronavirus infections nationwide,
'We do our best': fuel shortages make Yemen doctors' lives even harder
By Reuters Staff SANAA (Reuters) - In the Yemeni capital Sanaa, Mohammed al-Ghazaaly's kidney dialysis machine often cuts out due to an escalating fuel shortage in the country's north. When the
EXCLUSIVE-'We're confident': Russia to share legal risks of COVID-19 vaccine
By Polina Ivanova and Anthony Boadle MOSCOW/BRASILIA (Reuters) - Russia is so confident in its COVID-19 vaccine that it will shoulder some of the legal liability should anything go wrong, rather than
COVID-19 vaccine makers see EU shield against side-effect claims
By Francesco Guarascio BRUSSELS (Reuters) - Vaccine makers will be indemnified in Europe if their COVID-19 shots cause unexpected side-effects, an industry official said on Tuesday, urging European
COVID 'firepower': Britain imposes 6-month curbs against second wave
By Guy Faulconbridge and Kate Holton LONDON (Reuters) - British Prime Minister Boris Johnson told people on Tuesday to work from home where possible and ordered bars and restaurants to close early to
Get serious! Careless French public riles COVID medics
By Yiming Woo MARSEILLE, France (Reuters) - David Fleyrat had almost cleared his Marseille hospital's intensive care ward of COVID-19 patients during the summer lull in new cases. Now the private unit
'Less is more' in updated VA/DoD lipid clinical guideline
By Reuters Staff NEW YORK (Reuters Health) - An updated clinical practice guideline for managing lipid levels from the U.S. Department of Veterans Affairs and Department of Defense (VA/DoD) recommends
Avelumab shows survival benefit against advanced urothelial cancer
By Reuters Staff (Reuters Health) - Adding avelumab to the best supportive care as maintenance therapy for advanced or metastatic urothelial cancer can significantly extend overall survival by 31% and
Relative age effect may skew ADHD diagnosis, treatment in young children
By Marilynn Larkin NEW YORK (Reuters Health) - In Finland, the youngest children in a classroom are more likely to receive medication for attention deficit hyperactivity disorder (ADHD) than their
U.S. Black women with breast cancer face delayed, longer-lasting treatment
By Lisa Rapaport (Reuters Health) - Black women diagnosed with breast cancer in the U.S. are more likely to experience delayed treatment initiation and prolonged treatment duration that white women, a
Smartphone app iCanQuit effective as smoking cessation aid
By Lisa Rapaport (Reuters Health) - A head-to-head clinical trial of two smoking cessation smartphone applications found that an app based on acceptance and commitment therapy (ACT) was more effective
Later receipt of gender-affirming care for youth linked to worse mental health
By Linda Carroll (Reuters Health) - Worse mental health may result when gender incongruent youth seek gender affirming care at an older age and a later stage of puberty, a new Canadian study suggests.
ERAS approach to cesarean delivery linked to less opioid use, length of stay, costs
By Marilynn Larkin NEW YORK (Reuters Health) - Using the evidence-based enhanced recovery after surgery (ERAS) program for cesarean delivery was associated with decreased opioid use, shorter length of
UPDATE 2-U.S. CDC takes down coronavirus airborne transmission guidance
(Adds comment from WHO official, background) By Reuters Staff (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Monday took down its guidance warning on possible airborne
UPDATE 1-CDC takes down warning on airborne spread
(Updates with current CDC guidance) By Reuters Staff (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) said on Monday it had posted guidance on possible transmission of the new
More than 150 nations join WHO-led global plan for COVID vaccines
By Stephanie Nebehay and Kate Kelland GENEVA/LONDON (Reuters) - A total of 156 countries have joined the global COVAX scheme intended to ensure fair distribution of supplies of future vaccines against
WHO says no change to COVID-19 transmission guidance after U.S. change
By Reuters Staff LONDON (Reuters) - The World Health Organization has not changed its policy on aerosol transmission of the coronavirus, an official said on Monday after U.S. health officials updated
UPDATE 1-More nurses allowed to leave as Philippines eases travel ban
(Recasts story originally published Sept. 17, adds reaction from nursing groups, workers) By Karen Lema MANILA (Reuters) - More than a thousand Philippine health workers will finally be allowed to
U.S. sets record with over 1 million coronavirus tests in a day
By Lisa Shumaker (Reuters) - The United States set a one-day record with over 1 million coronavirus diagnostic tests being performed, but the country needs 6 million to 10 million a day to bring
Royal Caribbean, Norwegian Cruise submit health protocols to CDC looking to set sail again
By Nivedita Balu and Helen Coster (Reuters) - Hoping to set sail again after a long halt due to the COVID-19 pandemic, Royal Caribbean Group and Norwegian Cruise Line Holdings Ltd said on Monday they
U.S. CDC says coronavirus could spread through air
By Reuters Staff (Reuters) - The U.S. Centers for Disease Control and Prevention has warned that COVID-19 could spread through airborne particles that can remain suspended in the air and travel beyond
Liquid biopsy might help detect, manage liver cancer in the future
By Will Boggs MD NEW YORK (Reuters Health) - Liquid biopsy could someday be useful for the early detection and clinical management of hepatocellular carcinoma (HCC), according to a new review.
Severe donor obesity does not worsen heart-transplant outcomes
By Reuters Staff NEW YORK (Reuters Health) - Transplantation of hearts from severely obese donors is not associated with worse post-transplant outcomes than when hearts from slimmer people are used,
Hydration guided by urine flow rate better for preventing contrast-associated acute kidney injury
By Will Boggs MD NEW YORK (Reuters Health) - Urine flow rate (UFR)-guided hydration using the RenalGuard system is better than left ventricular end-diastolic pressure (LVEDP)-guided hydration for
Epidemiologist named new Czech health minister as COVID-19 cases surge
By Jason Hovet PRAGUE (Reuters) - Czech Prime Minister Andrej Babis nominated a top epidemiologist to become health minister on Monday after the previous minister quit over a sharp rise in COVID-19
